Colorectal cancers differ in respect of PARP-1 protein expression

Violetta Sulzyc-Bielicka, Pawel Domagala, Jolanta Hybiak +3

Recent findings raise the possibility of PARP inhibitor therapy in colorectal cancers(CRCs). However, the extent of PARP-1 protein expression in clinical specimens of CRC is not kn…